OrbiMed’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
211,300
+31,400
| +17% | +$1.68M | 0.28% | 56 |
|
|
2025
Q1 | $7.28M | Buy |
179,900
+113,900
| +173% | +$4.61M | 0.17% | 69 |
|
|
2024
Q4 | $1.84M | Buy |
+66,000
| New | +$1.84M | 0.04% | 98 |
|
|
2023
Q4 | – | Sell |
-350,000
| Closed | -$17.7M | – | 111 |
|
|
2023
Q3 | $17.7M | Buy |
350,000
+150,500
| +75% | +$7.61M | 0.38% | 66 |
|
|
2023
Q2 | $9.31M | Buy |
+199,500
| New | +$9.31M | 0.17% | 88 |
|